1 / 48

Urinary Incontinence in Women

Urinary Incontinence in Women. Clinical management guideline for Obstetrician-Gynecologist Number 63, June 2005 부산백병원 산부인과 R3 서 영 진. ETIOLOGY. 10~70% of women Increase gradually during young adult life, broad peak around middle age, steadily increase in the elderly

shanon
Télécharger la présentation

Urinary Incontinence in Women

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Urinary Incontinence in Women Clinical management guideline for Obstetrician-Gynecologist Number 63, June 2005 부산백병원 산부인과 R3 서 영 진

  2. ETIOLOGY • 10~70% of women • Increase gradually during young adult life, broad peak around middle age, steadily increase in the elderly • Most women do not seek medical help • Cost: $12.43 billion in USA

  3. Among ambulatory women : urodynamic stress incontinence (29~75%) : detrusor overactivity (7~33%) : mixed forms • Among older : stress incontinence ↓ : detrusor abnormalities & mixed forms↑ • Increase age (>70 years) : more severe and troublesome incontinence

  4. DIAGNOSIS • History and voiding diary : voiding daily (3- to 7-day) -diurnal voiding frequency nocturnal voiding frequency number if incontinence episodes : medical– pulmonary(coughing)bowel(constipation) neurologic- diabetes, stroke, lumbar disk disease gynecologic- pelvic organ prolapse obstetric surgical- hysterectomy, vaginal repair, RTx ...

  5. Physical examination : palpation of the ant. vaginal wall & urethra - urethral discharge or tenderness → diverticulum, inflammation, neoplasm : pelvic examination - vulvar, vaginal atrophy in menopausal state  ant. vaginal relaxation, prox. urethral detachment, ant. vaginal scarring, prolapse, cystocele, recto- cele

  6. : bimanual & rectal examination - anal sphincter tone, laceration anorectal pathology fecal impaction : neurologic examination - S2~S4 (controlling micturition) bulbocavernosus m. levators, ext. anal sphincter lower extremity motor (along sacral dermatomes)

  7. Measuring urethral mobility : aids in the diagnosis of incontinence & in planning treatment : predicting mobility by examination- inaccurate : Q-tip test - placement of a cotton swab in the urethra to the level of the vesical neck and measurement of the axis change with straining

  8. : stress incontinence- urethral hypermobility : but, when abnormality of voiding or detrusor → require the measurement of detrusor pressure during filling and emptying : other test (perineal USG, MRI) - be used for assessment of bladder neck mobility

  9. Laboratory tests : urinalysis- bacteriuria : blood test (BUN, Cr, glucose, Ca) - renal function : urine cytology- not recommended in incontinence - but, hematuria or acute onset of irritative voiding  cistoscopy & cytology to exclude neoplasm

  10. Office evaluation of bladder filling and voiding : office setting - the amount of urine the time of normal voiding residual urine volume (catheter, ultrasound) - bladder capacity (syringe, bulb) cough stress test

  11. Urodynamic test : cystometry - test of detrusor function - assess bladder sensation, capacity, compliance - determine the presence of both voluntary and involuntary detrusor contractions : uroflowmetry - electronic measure of urine flow rate and pattern

  12. : electromyography - striated urethral sphincter - assess neurogenic voiding dysfunction : postvoid residual urine volume - < 50 mL adequate voiding > 200 mL inadequate voiding - 50~200 mL → repeat test

  13. Cystourethroscopy : bladder lesion (diverticula, fistula, stricture …) foreign bodies : evaluation of postop. Incontinence and other intraop. or postop. lower urinary tract complication

  14. MANAGEMENT OPTIONS : absorbent products are most common method : but, with mild symptoms  cannot be cured depend on barrier management

  15. Behavioral approaches : lifestyle intervention - weight loss, caffeine reduction, fluid manage, reduction of physical force (work, exercise), cessation smoking, relief of constipation : bladder training - bladder drills or timed voiding - increase the interval between voiding - patient education, scheduled voiding

  16. : pelvic muscle exercise - ‘Kegel’ exercise - strengthen the voluntary peritrethral and peri- vaginal muscles (urethral sphincter, levator ani) - with bladder training, bio feedback, electrical stimulation

  17. 케겔운동의 방법 ▶1단계 : 소변을 참을 때를 연상하며 질을 1초 동안 수축했다가 긴장을 푸는 것을 반복합니다. ▶2단계 : 1단계가 익숙해지면 질을 5∼10초 동안 수축했다가 긴장을 푸는 것을 반복합니다. ▶3단계 :질의 근육을 마치 질이 물을 빨아올리듯이 뒤에서 앞 으로 수축하고 다시 물을 내뱉듯이 풀어버립니다. 한 번에 10회씩 하루 다섯 번 반복합니다. :케겔운동은 쉽게 말해 소변을 참을 때를 연상하며 질을 조였다 풀기를 반복하는 것입니다. 이 때, 질근육만을 수축하고 다리 엉덩이 근육은 움직이지 않는 것이 요령입니다. 하루에 20회 정도로 시작해서 점차 400회 정도까지 늘려나갑니다

  18. Medical management : urethra and bladder contain a rich supply to estrogens receptors - estrogen affects postmenopausal urogenic symptoms →however, increase in urinary incontinence : other agents for frequency, urgency, incontinence - unpredictable response, side effect ↑

  19. : drugs improve detrusor overactivity by inhibiting the contractile activity of bladder - anticholinergic agents tricyclic antidepressants musculotropic drugs

  20. Surgical treatments I. retropubic colposuspension - suspend and stabilize the ant. vaginal wall, bladder neck and prox. urethra → prevent their descents and allows for urethral compression against a stable urethral layer - technique two or three nonabsorbable sutures on each side of the mid urethra and bladder neck

  21. II. tension-free vaginal tape - impairment of the pubourethral ligaments - polypropylene mesh is placed at the mid urethra - other material and modified methods III. bulking agents(collagen, carbon beads, fat) inject - around bladder neck and prox. urethra - transurethrally, periurethrally - usually, second line therapy, nonmobile bladder neck and high risk of operation

  22. : complications - lower urinary tract injury, hemorrhage, bowel injury, wound complications, retention, UTI - perform cystoscopy to verify urethral patency and the absence of sutures or sling material in the bladder : incontinence with pelvic organ prolapse - uterine prolapse, cystocele - reduced or repaired (potential incontinence)

  23. CLINICAL CONSIDERATIONS AND RECOMMENDATIONS • When is office evaluation of bladder filling, voiding, or cystometry useful for evaluation of incontinence? :whenever objective clinical findings do not correlate with symptoms, bladder filling and cough stress tests are useful : monitored periodically to evaluate response : patient fails to improve to her satisfaction

  24. : retrograde bladder filling - bladder sensation and capacity - normal range : 300~700 mL but, large capacity are not always pathologic (33% of >800mL capacity:urodynamically normal) (13% : true bladder atony) : loss of urine with coughing and absence of urge - suggests urodynamic stress incontinence : prolonged loss of urine(5~10 seconds after cough) no urine loss with provocation - other cause (detrusor ovaractivity)

  25. : artifact introduced by increases in intraabdominal pressure caused by straining or movement - so, tests should be repeated : cystometric test - more complex disorder (ex. neurogenic) - measurements of detrusor pressure

  26. When are urethral pressure profilometry and leak point pressure measurements useful for evaluation of incontinence? : urethral pressure profilometry - not standardized able to contribute to the DDx. : leak point pressure measurement - amount of increase in intraabdominal pressure that cause stress incontinence

  27. When is cystoscopy useful for evaluation of incontinence? : sterile hematuria, pyuria, irritative voiding, pain, recurrent cystitis, in the absence of any reversible causes, suburethral mass, when urodynamic testing fails to duplicate symptoms : bladder lesion - < 2% : not routinely

  28. Are pessaries and medical devices effective for the treatment of urinary incontinence? : support bladder neck - may be effective for some cases : replacement of the prolapsed ant. vaginal wall with a pessary - responsible for either continence or some degree of urinary retention

  29. Are behavior modifications (eg, bladder retraining, biofeedback, weight loss) effective for the treatment of urinary incontinence? : individualized scheduled voiding, diary keeping, pelvic muscle exercise - 50 % reduction of incontinence episodes (15% in controls) - this was maintained for 6 months - no differences in treatment efficacy by type of incontinence (stress, urge, mixed)

  30. : behavior training with biofeedback -63% mean reduction : with pelvic floor electrical stimulation -did not result in significantly greater improvement  behavior therapy can be recommended as a noninvasive treatment in many women

  31. : combining drugs therapy- not enough evidence : obesity - 4.2-fold greater risk of stress incontinence

  32. Are pelvic muscle exercises effective for the treatment of urinary incontinence? : better than no treatment or placebo : reduces incontinence and increases vaginal pressure

  33. Is pharmacotherapy (eg, estrogen, tolterodine, oxybutynin, imipramine) effective for the treatment of urinary incontinence? : post menopausal women with at least one episode if incontinence weekly - exacerbation incontinence hormone therapy :39% placebo: 27% : another study - both combination HT or unopposed estrogen → increase the incidence of incontinence

  34.  oral estrogen regimen cannot be recommended as treatment or prevention for incontinence : anticholinergics (oxybutin chloride, tolteridine) - therapy for bladder overactivity → small benefit but, side effect (dry mouth, blurred vision, constipation, nausea, dizziness, headache)

  35. Is ther a role for bulking agents in the treatment of urinary incontinence? : gultaraldehyde cross-linked collagen - cure rate : 7~83% over 10-year period - limitation : durability and long-term results - two or three injections are likely to be required to achieve a satisfactory result

  36. When is surgery indicated for urinary incontinenece? : conservative treatments have failed patient wishes further treatment : not all patients need urodynamic testing before surgery : if detrusor overactivity patient - appropriate behavioral and medical therapy

  37. Which type of surgery is indicated in the treatment of urinary incontinence? : retropubic colposuspension - urodynamic stress incontinence hypermobile prox. urethra and bladder neck - depend on many factor need for laparotomy for other pelvic desease pelvic organ prolapse, age and health - but long term result (sling op. is better) - add hysterectomy → little to the efficacy in curing incontinence

  38. : retropubic suspension and sling procedure more efficacious than transvaginal needle susp- ension or anterior colporrhaphy with slightly higher complication rates : Burch colposuspension vs. tension-free tape - cure rate (57% vs. 66%) - Burch : delayed voiding, op. time↑, return time to normal activity ↑ tension-free tape : bladder injury ↑

  39. : paravaginal defect repair vs. Burch colposuspension - after 3 years continent rate (62% vs. 100%) : laparocopic Burch op. is better? - inconclusive : tension-free tape - cured 85% , improved 10.6%, failure 4.7% similar cure rate with Burch colposuspension

  40. for the patients with both prolapse and urinary incontinence, what surgical procedures are appropriate? : have a number of treatment options : abdominally, sacral colpopexy or retropubic clposuspension transvaginally, sling placed operation

  41. SUMMARY • Behavioral therapy (bladder training and prompt voiding) improved incontinence and can be recommended in many women • Pelvic floor training : to be an effective treatment for stress and mixed incontinenece • Pharmacologic agents(oxybutynin, tolterodine) : small benefit in detrusor overactivity women

  42. Cytometric test : nor routinely • Bulking agent : relatively noninvasive : when operation is contraindication • Burch colposuspension and sling procedure : long-term data is similar : depend on patient characteristics and surgeon’s exrerience

  43. Combination of hysterectomy and Burch op. : not result in higher continence rates than Burch procedure alone • Tension-free vaginal tape and open Burch colposuspension have similar success rate • Ant. colporrhaphy, needle urethropexy, paravaginal defect repair : lower cure rates than Burch procedure

More Related